to remove filtersHealthcare PR - February 2011
21 Feb 2011 | by Claire Murphy
As pharma companies negotiate the prospect of a fundamentally changed NHS and a new drug pricing system, our writers look for the threats and opportunities of the new landscape. Plus - interview with GSK's v-p, global comms, Phil Thomson.
